Back

HistoIndex Is Now MedTech Imaging Partner of Strategic Collaboration by A*STAR's GIS, NUS Medicine and Novo Nordisk

HistoIndex is very happy to be on board this strategic research collaboration by A*STAR's GIS, NUS Medicine and Novo Nordisk as one of the MedTech imaging partners.

Our AI-based stain-free digital pathology platform will contribute towards identifying patients with nonalcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), by providing a precise quantification of NAFLD/NASH characteristics.

Click to read more on how this study can further support the development of effective diagnostics and therapies.

GIS, NUS, AND NOVO NORDISK TEAM UP TO STUDY NON-ALCOHOLIC FATTY LIVER DISEASE IN ASIAN POPULATIONS

Back

Our site uses cookies or similar technologies to recognise your repeated visits and preferences for us to deliver an optimal browsing experience. Please remember to read our privacy statement.

By clicking on "I Accept" or "X" to continue your browsing on this site, you consent to the use of the cookies. To find out how you can disable cookies on your device, please click here.

I Accept